Morningstar Launches CLO Index Suite with Houlihan Lokey, Expanding Post-CRSP Product Reach

What happened

Morningstar announced a collaboration with Houlihan Lokey to develop daily valuation indexes for the CLO market, extending its index platform beyond traditional equity and fixed income benchmarks. The move leverages Morningstar’s post-CRSP scale and data capabilities, targeting a complex asset class where daily valuations have been limited. While the announcement demonstrates product innovation that supports the bull case for the index business, the financial impact is likely modest near-term given CLO indexing is nascent. The partnership also signals Morningstar’s willingness to partner with investment banks to create niche index products, diversifying revenue streams away from heavy reliance on Vanguard. However, the core investment thesis remains dependent on CRSP integration and Vanguard continuity, which this news does not materially change.

Implication

This CLO index initiative is a positive step toward diversifying Morningstar’s index revenue beyond equity benchmarks and demonstrates product innovation prowess. However, the near-term revenue contribution will be small, and the success of the index strategy still hinges on successful CRSP integration and maintaining the Vanguard relationship. Investors should view this as an incremental bullish data point but not as a reason to change position sizing until post-close financials reveal CRSP monetization traction.

Thesis delta

The thesis shifts moderately positive as Morningstar shows ability to innovate and expand index offerings into new asset classes (CLOs), supporting the bull case of organic adoption. However, the core thesis still depends on CRSP integration and Vanguard continuity, which remain unquantified. This news incrementally improves the probability of achieving the bull case revenue trajectory for indexes.